Floris H P van Velden
Overview
Explore the profile of Floris H P van Velden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Weeda Y, Kalisvaart G, van Velden F, Gelderblom H, van der Molen A, Bovee J, et al.
Diagnostics (Basel)
. 2022 Nov;
12(11).
PMID: 36359564
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms. Tyrosine kinase inhibitor (TKI) therapy is currently part of routine clinical practice for unresectable and metastatic disease. It is important to assess...
22.
Boekestijn I, van Oosterom M, Delloglio P, van Velden F, Pool M, Maurer T, et al.
Cancer Imaging
. 2022 Sep;
22(1):48.
PMID: 36068619
Molecular imaging technologies are increasingly used to diagnose, monitor, and guide treatment of i.e., cancer. In this review, the current status and future prospects of the use of molecular imaging...
23.
van Velden F, de Geus-Oei L
Diagnostics (Basel)
. 2022 Aug;
12(8).
PMID: 36010339
Since the introduction of personalized (or precision) medicine, where individually tailored treatments are designed to deliver the right treatment to the right patient at the right time, the primary focus...
24.
Noortman W, Vriens D, de Geus-Oei L, Slump C, Aarntzen E, van Berkel A, et al.
Eur Radiol
. 2022 Aug;
32(10):7227-7236.
PMID: 36001126
Objectives: Based on germline and somatic mutation profiles, pheochromocytomas and paragangliomas (PPGLs) can be classified into different clusters. We investigated the use of [F]FDG-PET/CT radiomics, SUV and biochemical profile for...
25.
Grootjans W, Rietbergen D, van Velden F
Semin Nucl Med
. 2022 Jun;
52(6):745-758.
PMID: 35643531
Positron emission tomography (PET) is an important imaging modality for personalizing clinical management of patients with lung cancer. In this regard, PET imaging is essential for adequate clinical staging and...
26.
Hendriks P, Rietbergen D, van Erkel A, Coenraad M, Arntz M, Bennink R, et al.
Cardiovasc Intervent Radiol
. 2022 May;
45(8):1057-1063.
PMID: 35618860
Purpose: To investigate the biodistribution of holmium-166 microspheres (Ho-MS) when administered after radiofrequency ablation (RFA) of early-stage hepatocellular carcinoma (HCC). The aim is to establish a perfused liver administration dose...
27.
Bijlstra O, Boreel M, van Mossel S, Burgmans M, Kapiteijn E, Oprea-Lager D, et al.
Diagnostics (Basel)
. 2022 Mar;
12(3).
PMID: 35328267
(1) Background: Up to 50% of patients with colorectal cancer either have synchronous colorectal liver metastases (CRLM) or develop CRLM over the course of their disease. Surgery and thermal ablation...
28.
Kalisvaart G, van Velden F, Hernandez-Giron I, Meijer K, Ghesquiere-Dierickx L, Brink W, et al.
Med Phys
. 2022 Feb;
49(5):3093-3106.
PMID: 35178781
Background: Accuracy and precision assessment in radiomic features is important for the determination of their potential to characterize cancer lesions. In this regard, simulation of different imaging conditions using specialized...
29.
de Koster E, Noortman W, Mostert J, Booij J, Brouwer C, de Keizer B, et al.
Eur J Nucl Med Mol Imaging
. 2022 Feb;
49(7):2174-2188.
PMID: 35138444
Purpose: To evaluate whether quantitative [F]FDG-PET/CT assessment, including radiomic analysis of [F]FDG-positive thyroid nodules, improved the preoperative differentiation of indeterminate thyroid nodules of non-Hürthle cell and Hürthle cell cytology. Methods:...
30.
Schalbroeck R, de Geus-Oei L, Selten J, Yaqub M, Schrantee A, van Amelsvoort T, et al.
Diagnostics (Basel)
. 2021 Dec;
11(12).
PMID: 34943640
Dopaminergic signaling is believed to be related to autistic traits. We conducted an exploratory 3,4-dihydroxy-6-[F]-fluoro-L-phenylalanine positron emission tomography/computed tomography ([F]-FDOPA PET/CT) study, to examine cerebral [F]-FDOPA influx constant ( min),...